Hong Kong – Senior appointment (with photo)

Senior appointment (with photo)

*******************************


     ​The Government announced today (May 3) that Mr Brian Lo Sai-hung, formerly Director-General of Trade and Industry, has taken up the post of Director of Administration on May 3, 2022.

      

     The Secretary for the Civil Service, Mr Patrick Nip, said, “Mr Lo is a seasoned Administrative Officer with proven leadership and management skills. I have every confidence that he will serve with professionalism in his new capacity.”

      

     A brief biographical note of Mr Lo is set out below:

 

Mr Brian Lo Sai-hung

—————————

 

     Mr Lo joined the Administrative Service in August 1989 and rose to the rank of Administrative Officer Staff Grade A in April 2021. He has served in various bureaux and departments, including the former City and New Territories Administration, the former Trade and Industry Branch, the former University and Polytechnic Grants Committee, the former Trade Department, the former Transport Bureau, the Innovation and Technology Commission, the former Housing, Planning and Lands Bureau, the Civil Service Bureau and the Trade and Industry Department. He was Deputy Secretary for Education from July 2014 to July 2018, Deputy Secretary for the Civil Service from July 2018 to August 2020 and has been serving as Director-General of Trade and Industry since August 2020.

Hong Kong – Senior Counsel appointed

Senior Counsel appointed

************************


The following is issued on behalf of the Judiciary:



     The Chief Justice of the Court of Final Appeal, Mr Andrew Cheung Kui-nung, is pleased to announce today (April 12) the appointment of five Senior Counsel of the Hong Kong Special Administrative Region. They are:



Ms Mairéad Mary Rattigan

Mr Johnny Ma Ka-chun

Ms Sara Tong See-pui

Mr Tony Li Chung-yin

Mr Victor Howard Joffe



     The appointments are made by the Chief Justice under section 31A of the Legal Practitioners Ordinance.



     The appointments will take effect from the date of the Instrument of Appointment, which will be executed on June 11, 2022, when, subject to the prevailing public health situation, the ceremonial proceedings are to take place at 10am in the Court of Final Appeal.



     Special seating arrangements will be made for ceremonial proceedings having regard to the limited capacity of the venue and the need for social distancing.



     The biographical notes of the newly appointed Senior Counsel are as follows:



Ms Mairéad Mary Rattigan



Ms Mairéad Mary Rattigan, aged 56, obtained a Bachelor of Laws degree from the University of London. She was admitted to the Bar of England and Wales (Inner Temple) in 1989 and to the Hong Kong Bar in 1990. She specialises in family law. 



Mr Johnny Ma Ka-chun



Mr Johnny Ma Ka-chun, aged 45, obtained a Bachelor of Laws degree from the University of Hong Kong and a Bachelor of Civil Law degree from the University of Oxford. He was admitted to the Hong Kong Bar in 1999. He has a general civil practice, focusing on probate and constitutional and administrative law matters.



Ms Sara Tong See-pui



Ms Sara Tong See-pui, aged 46, obtained a Bachelor of Arts degree in Law from the University of Cambridge. She was admitted to the Hong Kong Bar in 2003. Apart from her general civil practice covering commercial, company and probate work, she is also regularly instructed in professional disciplinary and securities regulatory matters.



Mr Tony Li Chung-yin



Mr Tony Li Chung-yin, aged 43, obtained a Bachelor of Laws degree and a Bachelor of Commerce degree from the University of New South Wales. He was admitted to the Hong Kong Bar in 2004. He specialises in criminal trial and appeal work.



Mr Victor Howard Joffe



Mr Victor Howard Joffe, aged 70, obtained a Bachelor of Arts degree, a Bachelor of Laws degree and a Master of Arts degree from the University of Cambridge. He was admitted to the Bar of England and Wales (Middle Temple) in 1975, to the New York State Bar in 1998, to the Inner Bar of England and Wales (Queen’s Counsel) in 2001, to the Eastern Caribbean Supreme Court in 2005, and to the Hong Kong Bar in 2011. He specialises in commercial and company litigation.   

Senior Management Further Increases Shareholdings in EC Healthcare With Strong Confidence in the Group’s Future Development

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group’s Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai further increases the shareholdings post the equity stake increase announced on January 17. Mr. Tang acquired a total 605,000 shares of the Company on the market for an aggregate consideration of approximately HK$ 4.96 million. On January 21, Mr. Tang acquired a total of 62,000 shares at an average price of approximately HK$8.49 per share and acquired a total of 543,000 shares at an average price of approximately HK$8.18 on January 22. After the transaction, Mr. Tang’s equity stake in the Group increased to 60.39%

In the past year, EC Healthcare has actively integrated the healthcare market through organic growth and acquisitions to further consolidate leading market position. As the epidemic has raged on in Hong Kong now, the Group also actively provides anti-epidemic medical services to the public through its general outpatient clinics, specialist clinics, health check centers, vaccine centers and laboratory centers. Looking forward, the Group remain confident for the long-term strong business growth momentum and will keep investing in IT, brand and service to provide better services to the public.”

About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020






Topic: Press release summary

42ND SENIOR MEN NATIONAL CYCLE POLO CHAMPIONSHIP 2021-22


Air Force Sports Control Board has always endeavoured to achieve excellence in sports and believes in professional indulgence. The AF teams have put forth noteworthy performances at all possible events/championships.


Air Force Cycle Polo team proved their mettle and emerged as the National Champions during the conduct of 42nd National Cycle Polo Championship held at Mysore from 17-20 Feb 22. Air Force Cycle Polo team beats Territorial Army in the finals by 17-12 goals and finished on top of the podium.


Air Marshal PP Bapat VSM (Retd) President, Cycle Polo Federation of India was the Chief Guest during the closing ceremony.


***


ABB/AM/ASG/JP




(Release ID: 1801120)
Visitor Counter : 253




Read this release in:



Hindi







Senior Management Increases Shareholdings in EC Healthcare With Strong Confidence in the Group’s Future Development

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 14 January 2022, the Group’s Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai (“Mr. Tang”) acquired a total of 543,000 shares of the Company on the market for an aggregate consideration of approximately HK$ 4.993 million at an average price of HK$9.1943 per share. As a result, Mr. Tang holds approximately 61.17% of the issued share capital of the Company. On 13 January 2022, Group’s Executive Director and Chief Digital Officer Mr. Wong Chi Cheung acquired 40,000 shares of the Company on the open market at an average price of HK$9.725 per share at a total consideration of approximately HK$389,000.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, “Benefiting from the rising health consciousness and the Group’s consistent investment focusing on the healthcare industry, the Group achieved a record high sales volume of no less than HK$880 million in the third quarter of the financial year 2022 (October – December 2021), representing a more than 40% y-o-y increase. Besides, the Group has already completed the previously announced Premier Medical Group (BVI) Limited and Bayley & Jackson Dental Surgeons Limited transactions. EC Healthcare is always devoted to developing an enclosed healthcare ecosystem to provide one-stop health medical service to customers. These two transactions further deepen the Group’s medical services layout. Looking forward, the Group remains confident about the long-term strong business growth momentum and will keep investing in IT, brand and service to consolidate the healthcare market.”

About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020

For further information, please contact:
iPR Ogilvy Limited
Callis Lau / Lorraine Luk / Charmaine Ip
Tel: (852) 2136 6952 / 2169 0467 / 3920 7649
Fax: (852) 3170 6606
Email: ech@iprogilvy.com






Topic: Press release summary